| Literature DB >> 25628398 |
Jean-Charles Nault1, Augusto Villanueva2.
Abstract
Hepatocellular carcinoma is a highly heterogeneous disease both at the molecular and clinical levels. Intratumor morphologic and genetic heterogeneity adds a new level of complexity in our understanding of liver carcinogenesis, and it is likely an important determinant of primary and secondary resistance to targeted therapies. Clin Cancer Res; 21(8); 1786-8. ©2015 AACR. See related article by Friemel et al., p. 1951. ©2015 American Association for Cancer Research.Entities:
Mesh:
Year: 2015 PMID: 25628398 DOI: 10.1158/1078-0432.CCR-14-2602
Source DB: PubMed Journal: Clin Cancer Res ISSN: 1078-0432 Impact factor: 12.531